AVXL
Anavex Life SciencesยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AVXL Profile
Anavex Life Sciences Corp.
A clinical stage biopharmaceutical company that develops novel drugs to treat Alzheimer's, central nervous system diseases and various types of cancer
630 5th Avenue
20th Floor
New York
NY USA 10111
--
Anavex Life Sciences Corp., founded on January 23, 2004, is located in Nevada. Is a clinical-stage biopharmaceutical company dedicated to the development of differentiated therapies that apply precision medicine to central nervous system (CNS) diseases with high unmet needs. The company's focus is on developing innovative therapies for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative diseases, rare diseases including Rett syndrome, and other central nervous system (CNS) diseases.
